What is Citigroup's price target for PEN?

Citigroup's latest stated price target for Penumbra Inc. (PEN) is $350, from its action on Dec 11, 2025.

What is Citigroup's rating on PEN?

Citigroup rates PEN Buy, a bullish rating, as of Dec 11, 2025.

When did Citigroup last change its view on PEN?

On Dec 11, 2025, Citigroup upgrades to Buy from Neutral, price target $350.

Citigroup PEN price target and rating history

Citigroup rates Penumbra Inc. (PEN) Buy with a $350 price target, as of its latest action on Dec 11, 2025. It has published 5 rating actions on PEN since February 2022, including 2 upgrades and 2 downgrades.

Current rating: Buy
Price target: $350
Median target, all firms: Too few
Actions on PEN: 5

Citigroup price target on PEN

Citigroup price target on PEN, each point a stated target, February 2022 to December 2025.

Every Citigroup rating on PEN

Dec 11, 2025
UpgradeCitigroup upgrades to Buy from Neutral, price target $350
Jul 31, 2024
DowngradeCitigroup downgrades to Neutral from Buy, price target $165 to $178
Nov 4, 2022
UpgradeCitigroup upgrades to Buy from Neutral, price target $217 to $212
Oct 5, 2022
DowngradeCitigroup downgrades to Neutral from Buy, price target $170 to $217
Feb 23, 2022
ReiterateCitigroup cuts its price target to $280 from $300, keeps Buy

How other firms rate PEN

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Citigroup	Buy	$350	Dec 11, 2025
Wells Fargo	Underweight	$15	Nov 18, 2025

Questions about Citigroup and PEN

What is Citigroup's price target for PEN?: Citigroup's latest stated price target for Penumbra Inc. (PEN) is $350, from its action on Dec 11, 2025.
What is Citigroup's rating on PEN?: Citigroup rates PEN Buy, a bullish rating, as of Dec 11, 2025.
When did Citigroup last change its view on PEN?: On Dec 11, 2025, Citigroup upgrades to Buy from Neutral, price target $350.

More PEN rating histories

All Citigroup ratings PEN news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.